Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Schlumberger NV (SLB) vs Viatris Inc (VTRS) Price & Performance

Schlumberger NVTrade
Viatris IncTrade

Price performance (Past 24H)

Key statistics

Schlumberger NV vs Viatris Inc — how do they compare? Schlumberger NV trades at $53.7 (market cap $79.67B), while Viatris Inc trades at $16.28 (market cap $18.69B). The key difference: Schlumberger NV is far larger — about 4.3× Viatris Inc's market cap, and Viatris Inc pays the higher dividend (2.95%). Which is the better fit depends on your goals.

SLBVTRS
Market Cap
$79.67B$18.69B
Sector
EnergyHealth
52-Week High
$58.01$17.86
52-Week Low
$31.72$9.49
Enterprise Value
$88.40B$30.80B
Dividend Yield
2.2%2.95%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Schlumberger NV

Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.

Read more on SLB

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Read more on VTRS